PACB · Pacific Biosciences of California Inc
United States · RS rating 79 · As of 2026-11-03
| Price | 2.44 USD |
|---|---|
| 1-day change | +3.8% |
| RS rating (overall / 1M / 3M / 12M) | 79 / 27 / 97 / 55 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 41 / 66 / 30 |
| Industry group (rank) | Medical-Systems/Equip (86) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +16.1% |
| Distance from 52-week high | +15.9% |
| Market cap (USD) | $474.1M |